abiraterone acetate

Abiraterone Acetate (CB7630) Phase II Data Released At The ASCO Annual Meeting

At the ASCO Annual meeting in Orlando Florida, Cougar Biotechnology, Inc. announced perliminary results from their ongoing Phase II clinical trials of their much discussed investigational drug abiraterone acetate (CB7630). The company released some preliminary encouraging data in three separate poster presentations. First, I want to tell you what abiraterone acetate is. In scientific jargon [...]

By Malecare|2017-10-19T10:54:28-04:00October 20th, 2009|abiraterone acetate, Advanced Prostate Cancer, Clinical Trials, Clinical Trials, On The Horizon, Uncategorized|0 Comments

CB7630 (Abiraterone Acetate) to Enter Phase III Trial

There is some good news on the horizon, or at least we are setting up for the possibility of some future good news. Coming off of the recent news about the very successful phase II trial of CB7630 (abiraterone acetate), Cougar Biotechnology, Inc. has reached agreement with the FDA under a special protocol assessment (SPA) [...]

By Malecare|2017-10-19T10:54:45-04:00July 26th, 2009|abiraterone acetate, Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, FDA, Research, Uncategorized|0 Comments

Previous 1920